Therefore, our results imply that SGO2, as a regulator of the cell cycle, promotes cell proliferation and may augment the metastatic ability of tumor cells, underscoring its prospective use as a new prognostic biomarker for LUAD. Here, SGO2 is linked to neoplasm.